Researchers have stopped dementia from developing in mice
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
A new study could change the way scientists approach dementia and Alzheimer's treatment.
Researchers at Duke University found a way to stop mice from developing dementia, BBC News reports. The scientists found that by blocking immune cells from breaking down arginine, an amino acid, they were able to stop the mice's immune systems from attacking nutrients. The researchers believe arginine deprivation could contribute to the development of Alzheimer's disease.
The study, published in the Journal of Neuroscience, found that mice who underwent the researchers' treatment did better on memory tests. The researchers' next test will involve providing the same drug, difluoromethylornithine, to older mice with advanced Alzheimer's, to see if it affects their condition.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"All of this suggests to us that if you can block this local process of amino acid deprivation, then you can protect the mouse, at least, from Alzheimer's disease," Dr. Matthew Kan, one of the study researchers, told BBC News. "We see this study opening the doors to thinking about Alzheimer's in a completely different way, to break the stalemate of ideas in Alzheimer's disease."
There are no drugs on the market to treat Alzheimer's disease, which affected as many as five million Americans in 2013.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
